Silvia Ravera1, Andrea Reyna-Neyra1, Giuseppe Ferrandino1, L Mario Amzel2, Nancy Carrasco1. 1. Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, Connecticut 06510; email: nancy.carrasco@yale.edu. 2. Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Abstract
Active iodide (I-) transport in both the thyroid and some extrathyroidal tissues is mediated by the Na+/I- symporter (NIS). In the thyroid, NIS-mediated I- uptake plays a pivotal role in thyroid hormone (TH) biosynthesis. THs are key during embryonic and postembryonic development and critical for cell metabolism at all stages of life. The molecular characterization of NIS in 1996 and the use of radioactive I- isotopes have led to significant advances in the diagnosis and treatment of thyroid cancer and provide the molecular basis for studies aimed at extending the use of radioiodide treatment in extrathyroidal malignancies. This review focuses on the most recent findings on I- homeostasis and I- transport deficiency-causing NIS mutations, as well as current knowledge of the structure/function properties of NIS and NIS regulatory mechanisms. We also discuss employing NIS as a reporter gene using viral vectors and stem cells in imaging, diagnostic, and therapeutic procedures.
Active iodide (n class="Chemical">I-) transport in both the thyroid and some extrathyroidal tissues is mediated by the Na+/I- symporter (NIS). In the thyroid, NIS-mediated I- uptake plays a pivotal role in thyroid hormone (TH) biosynthesis. THs are key during embryonic and postembryonic development and critical for cell metabolism at all stages of life. The molecular characterization of NIS in 1996 and the use of radioactive I- isotopes have led to significant advances in the diagnosis and treatment of thyroid cancer and provide the molecular basis for studies aimed at extending the use of radioiodide treatment in extrathyroidal malignancies. This review focuses on the most recent findings on I- homeostasis and I- transport deficiency-causing NIS mutations, as well as current knowledge of the structure/function properties of NIS and NIS regulatory mechanisms. We also discuss employing NIS as a reporter gene using viral vectors and stem cells in imaging, diagnostic, and therapeutic procedures.
Entities:
Keywords:
NIS mutations; gene transfer studies; imaging and radioiodide therapy; sodium/iodide symporter; structure/function; thyroid hormones
Authors: Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard Vile; Kevin Harrington Journal: Curr Cancer Drug Targets Date: 2010-03 Impact factor: 3.428
Authors: C Di Cosmo; G Fanelli; M Tonacchera; E Ferrarini; A Dimida; P Agretti; G De Marco; P Vitti; A Pinchera; G Bevilacqua; A G Naccarato; P Viacava Journal: Clin Endocrinol (Oxf) Date: 2006-10 Impact factor: 3.478
Authors: A Boland; M Ricard; P Opolon; J M Bidart; P Yeh; S Filetti; M Schlumberger; M Perricaudet Journal: Cancer Res Date: 2000-07-01 Impact factor: 12.701
Authors: Roisin M Dwyer; Elizabeth R Bergert; Michael K O'connor; Sandra J Gendler; John C Morris Journal: Clin Cancer Res Date: 2005-02-15 Impact factor: 12.531
Authors: Nabil E Boutagy; Silvia Ravera; Xenophon Papademetris; John A Onofrey; Zhen W Zhuang; Jing Wu; Attila Feher; Mitchel R Stacy; Brent A French; Brian H Annex; Nancy Carrasco; Albert J Sinusas Journal: Circ Cardiovasc Imaging Date: 2019-07-12 Impact factor: 7.792
Authors: Rachel R Kaspari; Andrea Reyna-Neyra; Lara Jung; Alejandra Paola Torres-Manzo; Sandro M Hirabara; Nancy Carrasco Journal: Proc Natl Acad Sci U S A Date: 2020-08-21 Impact factor: 11.205
Authors: Giuseppe Ferrandino; Rachel R Kaspari; Olga Spadaro; Andrea Reyna-Neyra; Rachel J Perry; Rebecca Cardone; Richard G Kibbey; Gerald I Shulman; Vishwa Deep Dixit; Nancy Carrasco Journal: Proc Natl Acad Sci U S A Date: 2017-10-10 Impact factor: 11.205